MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment?

Lung Cancer. 2003 Nov;42(2):189-93. doi: 10.1016/s0169-5002(03)00291-5.

Abstract

Magnetic resonance imaging (MRI) of the brain and extensive neurological examination by a neurologist was performed as part of initial staging evaluation of 91 neurologic asymptomatic patients with large cell carcinoma or adenocarcinoma of the lung. Patients were followed up for at least 6 months. Evidence of metastatic brain disease was documented in 13 (14%) patients. Two of these patients were found suspective of brain metastases (BM) by the neurologist. The detection of BM resulted in upstaging of 1 (3%) patient in stage I/II, 4 (21%) patients in stage IIIA and 2 (11%) patients in IIIB. Especially for patients in stage III this upstaging is of importance as aggressive locoregional treatment can be abandoned. Evaluation of the brain with MRI is a sensitive method of detecting BM in neurologic asymptomatic patients and is recommended as part of the initial staging of patients with large cell carcinoma or adenocarcinoma of the lung in stage III. Additional examination by the neurologist is of little value to provide information of the neurologic status.

MeSH terms

  • Adenocarcinoma / diagnosis*
  • Adenocarcinoma / pathology
  • Adenocarcinoma / secondary*
  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / pathology
  • Brain Neoplasms / secondary*
  • Carcinoma, Large Cell / diagnosis*
  • Carcinoma, Large Cell / pathology
  • Carcinoma, Large Cell / secondary*
  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Diagnosis, Differential
  • Female
  • Humans
  • Lung Neoplasms / pathology*
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged
  • Neurologic Examination
  • Prognosis
  • Sensitivity and Specificity